Portage Biotech (ATON) - רווח נקי למניה (EPS TTM)

The fundamental TTM net income per share metric helps assess the impact of crypto-asset volatility and regulatory risks on the AlphaTON Capital (ATON) strategy. The current value of 0.00 reflects the baseline level of the metric amid a cash deficit and the depletion of reserves. Meanwhile, the cyclical nature of biotech investments and dependence on market risk appetite determine the company's overall yield dynamics.

Net income per share (TTM) determines the actual earnings per security, balancing business stability against the risk of stagnation. This metric is calculated as the total profit over four quarters divided by the number of shares outstanding. By analyzing the rolling annual net income per share, an investor can track the dynamics of fundamental value. For AlphaTON Capital (ATON), this metric reflects the costs associated with developing immuno-oncology platforms. Investments in clinical trials for cancer therapy currently define the specific characteristics of this indicator.